Starost, Laura
Lindner, Maren
Herold, Martin
Xu, Yu Kang T.
Drexler, Hannes C. A.
Heß, Katharina
Ehrlich, Marc
Ottoboni, Linda
Ruffini, Francesca
Stehling, Martin
Röpke, Albrecht
Thomas, Christian
Schöler, Hans R.
Antel, Jack
Winkler, Jürgen
Martino, Gianvito
Klotz, Luisa
Kuhlmann, Tanja http://orcid.org/0000-0002-0174-5042
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG CRC-TR-128B07, CRC-TR-128Z02, CRC-TR-128A08)
Progressive MS Alliance (PA-1604-08492, PA-1604-08492, PA-1604-08492)
National Multiple Sclerosis Society (RG-1801-30020)
Italian Multiple Sclerosis Foundation (Neural Stem Cells in MS)
European Leukodystrophy Association (2017-018C4A)
Universitätsklinikum Münster
Article History
Received: 29 March 2020
Revised: 30 July 2020
Accepted: 22 August 2020
First Online: 7 September 2020
Compliance with ethical standards
:
: TK and ME have a pending patent application for the generation of human oligodendrocytes.